scholarly article | Q13442814 |
P50 | author | Robert H Mealey | Q57038141 |
P2093 | author name string | D P Knowles | |
L S Kappmeyer | |||
L N Wise | |||
P2860 | cites work | Comparative genomic analysis and phylogenetic position of Theileria equi | Q28278882 |
Babesia--a historical overview | Q28300030 | ||
Growth-inhibitory effect of heparin on Babesia parasites | Q31034189 | ||
Sporogony and experimental transmission of Babesia equi by Boophilus microplus | Q32064502 | ||
Cardiac arrhythmias associated with piroplasmosis in the horse: a case report | Q33371518 | ||
Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity. | Q33702830 | ||
Molecular sequence evidence for the reclassification of some Babesia species | Q34001213 | ||
Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk | Q34412745 | ||
Development of specific immunoglobulin Ga (IgGa) and IgGb antibodies correlates with control of parasitemia in Babesia equi Infection | Q34429334 | ||
The role of international transport of equine semen on disease transmission | Q34463699 | ||
Growth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures | Q34820970 | ||
PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings | Q35789246 | ||
Equine piroplasmosis associated with Amblyomma cajennense Ticks, Texas, USA. | Q35847518 | ||
Equine piroplasmosis: a review | Q35930695 | ||
Erythrocyte invasion by Babesia parasites: current advances in the elucidation of the molecular interactions between the protozoan ligands and host receptors in the invasion stage | Q36407687 | ||
Persistently infected horses are reservoirs for intrastadial tick-borne transmission of the apicomplexan parasite Babesia equi | Q36804299 | ||
Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential | Q37392812 | ||
Phylogeny and evolution of the piroplasms | Q38568823 | ||
Sequence heterogeneity in the gene encoding the rhoptry-associated protein-1 (RAP-1) of Babesia caballi isolates from South Africa | Q38908189 | ||
Development and evaluation of real-time PCR assays for the quantitative detection of Babesia caballi and Theileria equi infections in horses from South Africa. | Q38908191 | ||
Sequence heterogeneity in the equi merozoite antigen gene (ema-1) of Theileria equi and development of an ema-1-specific TaqMan MGB assay for the detection of T. equi | Q38908195 | ||
Observations on the Development ofBabesia caballi(Nuttall) in the Tropical Horse TickDermacentor nitensNeumann | Q39072303 | ||
Transmission of Babesia caballi by Dermacentor nitens (Acari: Ixodidae) is restricted to one generation in the absence of alimentary reinfection on a susceptible equine host | Q39441358 | ||
Dermacentor variabilis and boophilus microplus (Acari: Ixodidae): experimental vectors of Babesia equi to equids | Q39491398 | ||
The development of Babesia (Theileria) equi (Laveran, 1901) in the gut and the haemolymph of the vector ticks, Hyalomma species | Q39622853 | ||
The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies | Q40017444 | ||
Outbreak of equine piroplasmosis in Florida | Q40296428 | ||
Protective effects of passively transferred merozoite-specific antibodies against Theileria equi in horses with severe combined immunodeficiency. | Q40322994 | ||
Expression of equi merozoite antigen 2 during development of Babesia equi in the midgut and salivary gland of the vector tick Boophilus microplus | Q40404226 | ||
Equine babesiosis associated with strenuous exercise: clinical and pathological studies in Jordan | Q40652499 | ||
Equine piroplasmosis an update on diagnosis, treatment and prevention | Q41015864 | ||
Transplacental transmission of Babesia equi (Theileria equi) from carrier mares to foals | Q41447530 | ||
Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses | Q42284417 | ||
Ability of the vector tick Boophilus microplus to acquire and transmit Babesia equi following feeding on chronically infected horses with low-level parasitemia | Q42536880 | ||
Detection of Babesia caballi and Babesia equi in Dermacentor nuttalli adult ticks | Q43577745 | ||
Detection of Babesia equi (Laveran, 1901) by nested polymerase chain reaction | Q43757211 | ||
Vaccination of donkeys against Babesia equi using killed merozoite immunogen | Q43981402 | ||
Diagnosis of equine piroplasmosis in Xinjiang province of China by the enzyme-linked immunosorbent assays using recombinant antigens | Q44123045 | ||
Clotrimazole, ketoconazole, and clodinafop-propargyl as potent growth inhibitors of equine Babesia parasites during in vitro culture | Q44525160 | ||
Combined immunodeficiency in horses: characterization of the lymphocyte defect | Q44658361 | ||
In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys | Q44686581 | ||
Red maple (Acer rubrum) leaf toxicosis in horses: a retrospective study of 32 cases | Q44868371 | ||
Molecular evidence for transplacental transmission of Theileria equi from carrier mares to their apparently healthy foals | Q44903014 | ||
The identification of Babesia equi in Australia | Q45155282 | ||
Molecular detection of Theileria equi and Babesia caballi in the bone marrow of asymptomatic horses | Q45193429 | ||
Transplacental transmission of Theileria equi in two foals born and reared in the United Kingdom | Q45202071 | ||
Prevention by polyamines of the curative effect of amicarbalide and imidocarb for Trypanosoma brucei infections in mice | Q46362550 | ||
Comparative efficacy of diminazene diaceturate and diminazene aceturate for the treatment of babesiosis in horses | Q46521644 | ||
A case of transplacental transmission of Theileria equi in a foal in Trinidad. | Q47600954 | ||
Prevalence of the causative agents of equine piroplasmosis in the South West of The Netherlands and the identification of two autochthonous clinical Theileria equi infections. | Q50518545 | ||
The distribution and ecological 'preferences' of the tick Amblyomma cajennense (Acari: Ixodidae), an ectoparasite of humans and other mammals in the Americas. | Q51194107 | ||
Standardisation and comparison of serial dilution and single dilution enzyme linked immunosorbent assay (ELISA) using different antigenic preparations of the Babesia (Theileria) equi parasite. | Q52022446 | ||
Theileria (Babesia) equi and Babesia caballi infections in horses in Galicia, Spain. | Q53272400 | ||
Serodiagnosis of experimental and natural Babesia equi and B. caballi infections. | Q53891280 | ||
Treatment of equine piroplasmosis (B caballi) with imidocarb dipropionate. | Q54381374 | ||
P433 | issue | 6 | |
P304 | page(s) | 1334-1346 | |
P577 | publication date | 2013-08-28 | |
P1433 | published in | Journal of Veterinary Internal Medicine | Q15762439 |
P1476 | title | Review of equine piroplasmosis | |
P478 | volume | 27 |
Q92118892 | A Review on Equine Piroplasmosis: Epidemiology, Vector Ecology, Risk Factors, Host Immunity, Diagnosis and Control |
Q41163025 | A field survey for the seroprevalence of Theileria equi and Babesia caballi in donkeys from Nuu Division, Kenya |
Q55716204 | Assessment of Draxxin® (tulathromycin) as an inhibitor of in vitro growth of Babesia bovis, Babesia bigemina and Theileria equi. |
Q92400262 | Assessment of equine piroplasmids in the Nhecolândia sub-region of Brazilian Pantanal wetland using serological, parasitological, molecular, and hematological approaches |
Q111741640 | Babesiosis and Theileriosis in North America |
Q42639361 | Chemotherapeutic efficacies of a clofazimine and diminazene aceturate combination against piroplasm parasites and their AT-rich DNA-binding activity on Babesia bovis |
Q35541217 | Clinical investigation on Theileria equi and Babesia caballi infections in Italian donkeys |
Q36888131 | Clofazimine Inhibits the Growth of Babesia and Theileria Parasites In Vitro and In Vivo |
Q36329050 | Detection of Babesia caballi and Theileria equi in Blood from Equines from Four Indigenous Communities in Costa Rica. |
Q36796648 | Detection of Theileria luwenshuni in sheep from Great Britain |
Q54263173 | Development and validation of a duplex real-time PCR assay for the diagnosis of equine piroplasmosis. |
Q93170926 | Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: A review |
Q50059185 | Epidemiologic studies on Theileria equi infections for grazing horses in Ili of Xinjiang province |
Q98188963 | Equine piroplasmosis: An insight into global exposure of equids from 1990 to 2019 by systematic review and meta-analysis |
Q99240213 | Exposure to ambient air causes degradation and decreased in vitro potency of buparvaquone and parvaquone |
Q90394853 | First molecular evidence of Babesia caballi and Theileria equi infections in horses in Cuba |
Q89835031 | Genetic Characterization of Piroplasms in Donkeys and Horses from Nigeria |
Q47739315 | Genetic Variation of the β-tubulin Gene of Babesia caballi Strains |
Q90181696 | Genetic characteristics of Theileria equi in zebras, wild and domestic donkeys in Israel and the Palestinian Authority |
Q91652299 | Great diversity of Piroplasmida in Equidae in Africa and Europe, including potential new species |
Q39090611 | Horse-Expert: An aided expert system for diagnosing horse diseases |
Q39983196 | Identification of piroplasm infection in questing ticks by RLB: a broad range extension of tick-borne piroplasm in China? |
Q50093358 | In vitro growth inhibition of Theileria equi by bumped kinase inhibitors |
Q91860944 | Infection dynamics of Theileria equi and Theileria haneyi, a newly discovered apicomplexan of the horse |
Q100385166 | Infection dynamics of Theileria equi in carrier horses is associated with management and tick exposure |
Q52572936 | Inflammatory Myopathy in Horses With Chronic Piroplasmosis. |
Q39014658 | Inhibition of the in vitro growth of Babesia bigemina, Babesia caballi and Theileria equi parasites by trifluralin analogues |
Q91408393 | Lumefantrine and o-choline - Parasite metabolism specific drug molecules inhibited in vitro growth of Theileria equi and Babesia caballi in MASP culture system |
Q28821648 | Mitochondrial Genome Sequences and Structures Aid in the Resolution of Piroplasmida phylogeny |
Q92534800 | Molecular Detection of Theileria ovis and Theleiria equi in Livestock from Palestine |
Q40827246 | Molecular Detection of Theileria spp. in Livestock on Five Caribbean Islands. |
Q90702693 | Molecular and serological survey of carnivore pathogens in free-roaming domestic cats of rural communities in southern Chile |
Q36787205 | Molecular detection of equine piroplasms in donkeys (Equus asinus) in North Khorasan province, Iran |
Q96813287 | Molecular evidence of Babesia caballi and Theileria equi in equines and ticks in Nigeria: prevalence and risk factors analysis |
Q52877863 | Novel description of force of infection and risk factors associated with Theileria equi in horses in Israel and in The Palestinian Authority. |
Q40465218 | Oxidative stress and DNA damage in horses naturally infected with Theileria equi. |
Q88687521 | Parasitological and molecular diagnostic of a clinical Babesia caballi outbreak in Southern Romania |
Q35446170 | Passive surveillance for ticks on horses in Saskatchewan |
Q93351245 | Prevalence and molecular characterization of piroplasmids in domestic dogs from Paraguay |
Q40579298 | Prospective study investigating transplacental transmission of equine piroplasmosis in thoroughbred foals in Trinidad |
Q90091405 | Rapid isothermal duplex real-time recombinase polymerase amplification (RPA) assay for the diagnosis of equine piroplasmosis |
Q93122076 | Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites |
Q39184336 | Sequence heterogeneity in the 18S rRNA gene in Theileria equi from horses presented in Switzerland |
Q90668943 | Serological, molecular and hematological diagnosis in horses with clinical suspicion of equine piroplasmosis: Pooling strengths |
Q39354941 | Seroprevalence and risk factors associated with Babesia caballi and Theileria equi infections in donkeys from Southern Italy. |
Q30096711 | Seroprevalence of Theileria equi and Babesia caballi in horses in Spain |
Q59353346 | Some aspects on tick species in Mongolia and their potential role in the transmission of equine piroplasms, Anaplasma phagocytophilum and Borrelia burgdorferi L |
Q89489548 | Stress conditions do not affect Theileria equi parasitemia levels in sub-clinically infected horses |
Q52807248 | The diversity of tick-borne bacteria and parasites in ticks collected from the Strandja Nature Park in south-eastern Bulgaria. |
Q91166872 | The first molecular detection and genetic diversity of Babesia caballi and Theileria equi in horses of Gansu province, China |
Q47118166 | Ticks and Tick-Borne Pathogens of the Caribbean: Current Understanding and Future Directions for More Comprehensive Surveillance |
Q89878713 | Transplacental Transmission of Theileria equi Is Not a Common Cause of Abortions and Infection of Foals in Israel |
Q90564095 | Variation in disease phenotype is marked in equine trypanosomiasis |
Q40059827 | Verification of post-chemotherapeutic clearance of Theileria equi through concordance of nested PCR and immunoblot. |